Professor of Clinical Translational Metabolism, Group Leader. #obesity University of Copenhagen @uni_copenhagen
København, Danmark
Joined February 2017
- Tweets179
- Following57
- Followers261
- Likes151
Pinned Tweet
Nu til aften også i Go’ aften Live studiet på TV2 kl 18.30 og fortælle om vores nye studie publiceret i The New England Journal of Medicine om sund vægttabsvedligeholdelse. Stor oplevelse.
🌟Extremely honored to receive the KROC visiting Professorship 2026 at the Mayo Clinic Division of Endocrinology, Minnesota, US
Thank you for a wonderful opportunity to meet all the excellent scientists and doctors ranked no 1 in US for the 30th time🥳
Signe S Torekov retweeted
👉SØG SØG DEL INDEN 18/8: Er du vores nye forskningskoordinator indenfor svær overvægtsforskning og behandling? jobportal.ku.dk/alle-opslag/… @BiomedUCPH @CTMetabUCPH @UCPH_Research
👉SØG SØG DEL INDEN 18/8: Er du vores nye forskningskoordinator indenfor svær overvægtsforskning og behandling? jobportal.ku.dk/alle-opslag/… @BiomedUCPH @CTMetabUCPH @UCPH_Research
Our new study is out in @CellRepMed showing that Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids: @Matteo_Fiorenza @CTMetabUCPH Cell Reports Medicine cell.com/cell-reports-medici…
Our new study is out in @JAMANetwork “Bone Health After Exercise Alone, GLP-1 Treatment, or Combination Treatment” 💪Excercise+GLP-1RA was the most effective weight loss strategy while preserving bone health
jamanetwork.com/journals/jam…
@SBKJensen @RasmusSandsdal @BiomedUCPH
Thank you very much to the @novonordiskfond for a Distinguished Investigator grant making it possible to conduct the FutureShape Family study for prevention of childhood obesity. I am most grateful, looking forward to initiate the study.
🎉@BiomedUCPH @CTMetabUCPH @UCPH_Research
Supported by a Distinguished Investigator grant, Professor Signe Torekov from the Department of Biomedical Sciences at University of Copenhagen will pioneer an innovative approach to prevent obesity in children. A study of 400 families dealing with obesity will consider how the weight and habits of parents affects their kids. Using AI to enhance physical activity levels, sleep and eating habits, the study hopes to change how we deal with childhood obesity. The ultimate goal is that healthier parents will lead to healthier children. The Distinguished Investigator grant is awarded as part of the Novo Nordisk Foundation’s Research Leader Programme, which aims to enable outstanding research while supporting the development of research leaders. Learn more here: novonordiskfonden.dk/en/news…
@STorekov @UCPH_Research
Signe S Torekov retweeted
Effects of 3 months of 10-h per-day time-restricted eating on bodyweight and cardiometabolic health in individuals at risk of type 2 diabetes: the RESET randomised controlled trial by @J_Salling_Quist and colleagues thelancet.com/journals/lanhl…
Signe S Torekov retweeted
#EASCongress2024 Adding exercise together w/ medications helps maintain healthy weight after medication. Living discussion also on calorie restriction and keto diets in Forum 2. I hope you didn't miss it!
@EASCongress @society_eas
Signe S Torekov retweeted
Fantastic talk, @STorekov !! Exploring ectopic fat and cardiometabolic diseases throughout life.
Signe S Torekov retweeted
Supported by a Distinguished Investigator grant, Professor Signe Torekov from the Department of Biomedical Sciences at University of Copenhagen will pioneer an innovative approach to prevent obesity in children. A study of 400 families dealing with obesity will consider how the weight and habits of parents affects their kids. Using AI to enhance physical activity levels, sleep and eating habits, the study hopes to change how we deal with childhood obesity. The ultimate goal is that healthier parents will lead to healthier children. The Distinguished Investigator grant is awarded as part of the Novo Nordisk Foundation’s Research Leader Programme, which aims to enable outstanding research while supporting the development of research leaders. Learn more here: novonordiskfonden.dk/en/news…
@STorekov @UCPH_Research
Signe S Torekov retweeted
This study underscores the multifaceted approach to obesity management, where the integration of exercise with pharmacotherapy, such as GLP-1 receptor agonists, enhances long-term weight maintenance outcomes. It's fascinating to see the positive effects persist even after a year without treatment. This adds a valuable piece to the puzzle of sustainable weight management strategies. For more in-depth analyses and a broader context on biomedical questions like this, I recommend checking out sciqst.com. SciQst leverages AI to generate comprehensive biomedical reviews, providing a one-stop solution for your biomedical inquiries, and it's free to use. #Medicine #ObesityManagement #WeightLoss
Signe S Torekov retweeted
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by 1 year no treatment
Addition of supervised exercise to obesity pharmacotherapy seems to improve healthy weight maintenance after treatment termination
thelancet.com/journals/eclin…
In TV2 Happy to share our new study in @TheLancet @eClinicalMed you can preserve weight loss after termination of medical #obesity treatment, but only if you #exercise.
@BiomedUCPH @CTMetabUCPH @UCPH_Research @SBKJensen @RasmusSandsdal @BenteStall @jensbruu
Happy to share our new study in @TheLancet @eClinicalMed you can preserve weight loss after termination of medical #obesity treatment, but only if you #exercise.
@BiomedUCPH @CTMetabUCPH @UCPH_Research @SBKJensen @RasmusSandsdal @BenteStall @jensbruu
sciencedirect.com/science/ar…
Thank you to #idrettsmedisinsk høstkongress for inviting me to present our studies on Healthy weight throughout life in the beauteful Trondheim
@trinemoholdt @JonMagne Morten Høgh (Hoegh)
#exercise #obesity #appetite
Signe S Torekov retweeted
Multiple reasons for weight loss and keeping the weight off @STorekov #Sportsmedisinskhøstkongres #Trondheim
Signe S Torekov retweeted
We are pleased to share the results of this human study thanks to a great collab. with @STorekov, which highlights endocannabinoid-related molecules as potential biomarkers of GLP-1R agonist efficacy in obesity.
link.springer.com/article/10….
Come and join us today for Simon Jensens PhD defense:Targeting the challenge of weight regain after weight loss in obesity management healthsciences.ku.dk/phd/cal…
